Revance Therapeutics shares owned by Hanson McClain Advisors
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Hanson McClain Advisors
from 13F filings
Historical chart of Hanson McClain Advisors investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Hanson McClain Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $4.0k | 820 | 4.92 |
| 2023-12-31 | $590 | 67 | 8.81 |
| 2023-09-30 | $1.5k | 132 | 11.48 |
| 2023-06-30 | $3.3k | 132 | 25.32 |
| 2023-03-31 | $14k | 432 | 32.21 |
| 2022-12-31 | $8.0k | 432 | 18.46 |
| 2022-09-30 | $12k | 432 | 27.78 |
| 2022-06-30 | $5.0k | 351 | 14.25 |
| 2022-03-31 | $7.0k | 368 | 19.02 |
| 2021-12-31 | $22k | 1.3k | 16.58 |
| 2021-09-30 | $10k | 351 | 28.49 |
| 2021-06-30 | $9.0k | 300 | 30.00 |
| 2021-03-31 | $8.0k | 300 | 26.67 |
| 2020-12-31 | $9.0k | 300 | 30.00 |